Zelira Therapeutics Ltd

ZLD

Company Profile

  • Business description

    Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

  • Contact

    101 St George’s Terrace
    Level 3
    PerthWA6000
    AUS

    T: +61 865580886

    https://www.zeliratx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    8

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries7,524.30323.30-4.12%
CAC 406,903.58371.37-5.10%
DAX 4019,651.51990.21-4.80%
Dow JONES (US)38,445.032,100.90-5.18%
FTSE 1007,721.46333.52-4.14%
HKSE19,828.303,021.51-13.22%
NASDAQ15,587.79962.82-5.82%
Nikkei 22531,136.582,644.00-7.83%
NZX 50 Index11,775.88449.40-3.68%
S&P 5005,084.85311.67-5.78%
S&P/ASX 2007,343.30324.50-4.23%
SSE Composite Index3,096.58245.43-7.34%

Market Movers